Previous reports have demonstrated that FOXM1 is oncogenic, in breast cancer [48], hepatocellular carcinoma [49], prostate cancer [50], lung cancer [51], and colorectal cancer [52], and plays important roles in angiogenesis, invasion, and metastasis [53]. Here, FOXM1 is linked to hepatocellular carcinoma.